Our proprietary nanocrystal platform addresses flavonoids’ core drawbacks of poor water solubility and low bioavailability. It converts insoluble flavonoid crystals into instantly dispersible nano powder with fully food-grade accessories, applicable to supplements, food and skincare. Lab preparation is feasible, yet mass production carries strict technical thresholds. We have established stable manufacturing lines; curcumin and quercetin are only test samples verifying the technology’s universal adaptability. Traditional flavonoids are barely absorbed in intestines and require high dosages, while rival solubilization techniques have cost or stability defects. Our process relies on physical particle crushing with flexible, low-cost production, compatible with all oral and cosmetic formulations. Complete dissolution, pharmacokinetic and functional test data supports partners’ product promotion and registration. By high-pressure homogenization, flavonoid particles are miniaturized to 200 nm. This delivers full rapid dissolution and stronger intestinal absorption without altering the natural activity of raw materials, with stabilizers preventing particle agglomeration. Minor production parameter deviations ruin product quality, a challenge most labs cannot overcome, unlike our mature mass-production system. Authoritative journal data proves 200 nm nanocrystals fully dissolve in 5 minutes versus incomplete dissolution of crude flavonoids after 3 hours. Their systemic exposure and peak blood concentration reach 9–10 times that of raw materials, bringing outstanding benefits including 99.3% abnormal cell repair and relieved respiratory inflammation. Microscopic tests confirm uniform, stable nano particle structure.
Sinochem Pharmaceutical Co., Ltd., founded in 1973 and headquartered in Nanjing, is a subsidiary of Sinochem Holdings. The company specializes in the pharmaceutical and medical device sectors, providing integrated services that include the R&D, customized synthesis, and processing of chemical drugs. It also manages comprehensive warehousing, logistics for medical devices, and regulatory services. With a focus on international markets, the company maintains a robust professional management team and holds certifications for GSP and ISO quality management systems.
The company serves global clients by bridging Chinese manufacturing capabilities with international standards. By leveraging its regulatory affairs team, Sinochem Pharmaceutical assists domestic manufacturers with factory auditing and cGMP compliance while facilitating the registration of products for export. Its portfolio spans antibiotics, antimalarials, vitamins, and treatments for cardiovascular, diabetes, and respiratory conditions. Through partnerships and strategic supply chain management, the company delivers value to global pharmaceutical entities in markets such as Europe, America, Japan, South Korea, and India.